Research institute
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 11, 2020.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at San Francisco’s Gladstone Institutes published research on bioRxiv—which means it has not been peer-reviewed—that demonstrated, in culture, how the virus damages cardiac muscles.
Could gene therapy provide a solution to HIV? A new research project aims to find out.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
A study published in the journal npj Precision Oncology on Sept. 1 featured data that suggested honeybee venom can potentially destroy triple-negative breast cancer and HER2-enriched breast cancer cells.
The use of structured data and automation can accelerate antibody engineering as much as 50%, Prem Mohanty, product marketing manager and life sciences product specialist for Benchling, told BioSpace.
A study published in Nature last week explains why certain kinds of cancer cells often spread to the lymph nodes before various organs within the body.
Researchers from the Salk Institute took a major step forward in developing a new insulin-producing pancreatic cell cluster as a potential treatment for type 1 diabetes patients.
Point-of-care testing is a critical tool in the battle against COVID-19, and researchers in Indiana are working around the clock to deliver rapid tests with high specificity.
PRESS RELEASES